Mudassar Asghar, MD
Neurology · Chester, VANPI 1225101553
Payments from drug & device makers
Across 234 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$896
- AbbVie$673
- Biogen$242
- Lundbeck LLC$170
- EMD Serono, Inc.$162
- Amgen$140
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 82 | $896 |
| AbbVie(2 entities) | 56 | $673 |
| Biogen | 14 | $242 |
| Lundbeck LLC | 4 | $170 |
| EMD Serono, Inc. | 10 | $162 |
| Amgen | 4 | $140 |
| Sanofi | 2 | $136 |
| AstraZeneca | 4 | $132 |
| UCB, Inc. | 7 | $126 |
| Biohaven Pharmaceuticals, Inc. | 2 | $125 |
| Genentech USA, Inc. | 1 | $125 |
| Assertio Therapeutics, Inc. | 11 | $124 |
| Adamas Pharmaceuticals, Inc. | 1 | $123 |
| Penumbra, Inc. | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 1 | $96 |
| Sunovion Pharmaceuticals Inc. | 1 | $90 |
| Insightec,inc | 1 | $70 |
| Kyowa Kirin, Inc. | 3 | $53 |
| SK Life Science, Inc. | 3 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $51 |
| GE HealthCare | 3 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Livanova USA, Inc. | 1 | $36 |
| Greenwich Biosciences, Inc. | 2 | $34 |
| Amneal Pharmaceuticals LLC | 2 | $31 |
| Neurocrine Biosciences, Inc. | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Abbott | 1 | $23 |
| Pfizer | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Banner Life Sciences, LLC | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$123
- VYEPTI$120
- NURTEC ODT$114
How this compares
$4,120 in reported general payments places this provider in the 60th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Chester
- Stacey EppsChester$109K
- Michelle BetzVirginia Beach$3.3M
- Daniel CohenNorfolk$2.9M
- Heidi CraytonVienna$2.5M
- Ramsey FalconerAlexandria$2.4M
- Robert ShinCharlottesville$2.2M
- Simon FishmanAlexandria$1.6M
- Ingrid Loma MillerNorfolk$1.2M
- Matthew BarrettHenrico$1.1M
- James BickselMc Lean$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.